Cargando…
Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes
OBJECTIVE: Interest continues to grow regarding the therapeutic potential for umbilical cord blood therapies to modulate autoimmune disease. We conducted an open-label phase I study using autologous umbilical cord blood infusion to ameliorate type 1 diabetes. RESEARCH DESIGN AND METHODS: Fifteen pat...
Autores principales: | Haller, Michael J., Wasserfall, Clive H., McGrail, Kieran M., Cintron, Miriam, Brusko, Todd M., Wingard, John R., Kelly, Susan S., Shuster, Jonathan J., Atkinson, Mark A., Schatz, Desmond A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768209/ https://www.ncbi.nlm.nih.gov/pubmed/19875605 http://dx.doi.org/10.2337/dc09-0967 |
Ejemplares similares
-
Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
por: Haller, Michael J., et al.
Publicado: (2011) -
Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017) -
339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.
por: Bruggeman, Brittany S, et al.
Publicado: (2022) -
Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
por: Williams, MacKenzie D., et al.
Publicado: (2021) -
Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for Immunoregulation
por: Brusko, Todd M., et al.
Publicado: (2009)